The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma
- PMID: 15015616
The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma
Abstract
Background: Reliable chemosensitivity testing of head and neck squamous cell carcinoma (HNSCC) still faces methodical limitations. Since stromal cell contamination has been found to preclude reliable radiosensitivity testing of HNSCC as well as chemosensitivity testing of lung tumors, the present study investigates the impact of stromal cell contamination on chemosensitivity testing of HNSCC.
Patients and methods: Seventeen biopsies from HNSCC were analyzed. The specimens were investigated using an ex vivo colony formation assay which allows for the quantitative and separate determination of the overall, as well as the epithelial, and stromal response to carboplatin, 5-fluorouracil and docetaxel.
Results: The overall chemoresponse was dominated by stromal cell multidrug resistance. However, by selective evaluation of the epithelial chemoresponse, individual chemosensitivity patterns could be identified.
Conclusion: Multidrug-resistant stromal cells preclude the reliable assessment of the chemoresponse of HNSCC specimens. Carefiul correction for stromal cell effects is a prerequisite for the generation of therapeutically useful information.
Similar articles
-
Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine.Anticancer Res. 2006 May-Jun;26(3B):2361-5. Anticancer Res. 2006. PMID: 16821617
-
Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations.Anticancer Res. 2006 Mar-Apr;26(2B):1651-5. Anticancer Res. 2006. PMID: 16619587
-
Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse.Cancer Chemother Pharmacol. 2010 May;65(6):1153-63. doi: 10.1007/s00280-009-1124-4. Epub 2009 Sep 22. Cancer Chemother Pharmacol. 2010. PMID: 19771432
-
[Ex-vivo-chemoresponse testing of head and neck cancer: an old hat?].Laryngorhinootologie. 2011 Aug;90(8):464-8. doi: 10.1055/s-0031-1283137. Epub 2011 Aug 1. Laryngorhinootologie. 2011. PMID: 21809229 Review. German.
-
Is there a role for chemosensitivity tests in head and neck cancer?Onkologie. 2004 Jun;27(3):310-5. doi: 10.1159/000077984. Onkologie. 2004. PMID: 15249723 Review.
Cited by
-
Primary cultures of mouse small intestinal epithelial cells using the dissociating enzyme type I collagenase and hyaluronidase.Braz J Med Biol Res. 2017 Apr 13;50(5):e5831. doi: 10.1590/1414-431X20175831. Braz J Med Biol Res. 2017. PMID: 28423120 Free PMC article.
-
[Pharmacological characterization of head and neck cancer in ex-vivo tests].HNO. 2011 Sep;59(9):866-73. doi: 10.1007/s00106-011-2362-4. HNO. 2011. PMID: 21847640 Review. German.
-
Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model.Oncotarget. 2018 May 18;9(38):25034-25047. doi: 10.18632/oncotarget.25244. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861851 Free PMC article.
-
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.Cancers (Basel). 2015 Aug 28;7(3):1716-42. doi: 10.3390/cancers7030858. Cancers (Basel). 2015. PMID: 26343729 Free PMC article. Review.
-
Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer.HSOA J Stem Cells Res Dev Ther. 2021;7(3):076. doi: 10.24966/srdt-2060/100076. Epub 2021 Sep 9. HSOA J Stem Cells Res Dev Ther. 2021. PMID: 34796266 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical